Anastasia Suraev - Medical Cannabis Research Engine

Affiliations

Organizations

Io Therapeutics (United States)authorship · US Macquarie Universityauthorship · AU The University of Sydneyauthorship · AU Woolcock Institute of Medical Researchauthorship · AU

Public evidence

18 connected articles

High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial.2026 · Europe PMC Use of Medicinal Cannabis for Epilepsy in the Australian Community 2023-2024: A Cross-Sectional Survey.2025 · Europe PMC Cannabidiol attenuates precuneus activation during appetitive cue exposure in individuals with alcohol use disorder.2025 · Europe PMC Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review.2024 · Europe PMC Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.2024 · Europe PMC The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial.2024 · Europe PMC Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).2024 · Europe PMC Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia.2024 · Europe PMC Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.2023 · PubMed Central Open Access Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey.2023 · PubMed Central Open Access The "Next Day" Effects of Cannabis Use: A Systematic Review.2023 · Europe PMC Orally administered cannabidiol does not produce false-positive tests for Δ<sup>9</sup> -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.2022 · Europe PMC Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).2022 · Europe PMC The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence.2022 · PubMed Central Open Access Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients2020 · PubMed Central Open Access Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).2020 · PubMed Central Open Access Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.2018 · Europe PMC Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.2018 · PubMed Central Open Access

Registered research

Connected studies

A Randomised, Double-blind, Placebo-controlled, Single-dose, Crossover, Pilot Study Investigating the Effects of Cannabinol (CBN) 30 mg and 300 mg on Sleep Architecture and Next-day Function in Insomnia Disordernct05344170 Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactionsnct06192589 The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence: An Exploratory Pilot Studynct05387148